Octave Guinebretiere

Paris, 75013, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).

Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).

Journal: Neurology
Published: June 05, 2026

Long-term effect of discontinuing anticholinesterase treatment on cognitive decline and mortality in Alzheimer's disease in France: a quasi-experiment and target trial emulation study.

Long-term effect of discontinuing anticholinesterase treatment on cognitive decline and mortality in Alzheimer's disease in France: a quasi-experiment and target trial emulation study.

Journal: The Lancet regional health. Europe
Published: October 09, 2025

Recurrence and Mortality After a First Status Epilepticus: A Retrospective Nationwide Study From the French National Health Data System.

Recurrence and Mortality After a First Status Epilepticus: A Retrospective Nationwide Study From the French National Health Data System.

Journal: Neurology
Published: May 19, 2025

Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11-year nationwide study.

Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11-year nationwide study.

Journal: Epilepsia
Published: April 30, 2025

Updated Multiple Sclerosis Incidence in France, 2011-2021.

Updated Multiple Sclerosis Incidence in France, 2011-2021.

Journal: Neurology
Published: April 14, 2025

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer's, Parkinson's and dementia at age 65: a study using medical records from France and the UK General Practitioners.

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer's, Parkinson's and dementia at age 65: a study using medical records from France and the UK General Practitioners.

Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025

Longitudinal comparative analysis of antidepressants and anti-anxiety medications in Alzheimer's and Parkinson's diseases: insights from French and British health records.

Longitudinal comparative analysis of antidepressants and anti-anxiety medications in Alzheimer's and Parkinson's diseases: insights from French and British health records.

Journal: Journal of affective disorders
Published: January 30, 2025

Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14-Year Nationwide Study (2010-2023).

Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14-Year Nationwide Study (2010-2023).

Journal: European journal of neurology
Published: January 09, 2025

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Journal: EBioMedicine
Published: July 29, 2024

Association Between Diseases and Symptoms Diagnosed in Primary Care and the Subsequent Specific Risk of Multiple Sclerosis.

Association Between Diseases and Symptoms Diagnosed in Primary Care and the Subsequent Specific Risk of Multiple Sclerosis.

Journal: Neurology
Published: December 05, 2023

Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification.

Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification.

Journal: Alzheimer's research & therapy
Published: December 05, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026